Want to see AZR full AI Analyst Report?
Azora Therapeutics (AZR) Income Statement
Azora Therapeutics Income Statement
Last quarter (Q2 2026), Azora Therapeutics's total revenue was $0.00. In Q2, Azora Therapeutics's net income was $-51.99M. See Azora Therapeutics’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Mar 24 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | |
| $ 0.00 | $ 0.00 | $ -564.00 | $ 0.00 | $ 0.00 | |
| $ 7.80M | $ 8.28M | $ 6.89M | $ 10.86M | $ 19.29M | |
| Depreciation and Amortization | $ 565.00 | $ 565.00 | $ 564.00 | $ 564.00 | $ 55.11K |
| $ -7.98M | $ -13.20M | $ -7.00M | $ -10.80M | $ -17.69M | |
| $ -7.80M | $ -8.28M | $ -6.89M | $ -10.86M | $ -19.29M | |
| $ -177.71K | $ -4.91M | $ -113.94K | $ 63.34K | $ -228.68K | |
| $ -7.98M | $ -13.20M | $ -7.00M | $ -10.80M | $ -19.52M | |
| $ -7.98M | $ -13.20M | $ -7.00M | $ -12.73M | $ -19.42M | |
| Per Share Metrics | |||||
| Basic EPS | $ -11.93 | $ -17.75 | $ -136.00 | $ -299.50 | $ -653.00 |
| Diluted EPS | $ -11.93 | $ -17.75 | $ -136.00 | $ -299.50 | $ -653.00 |
| Weighted Average Shares Outstanding | 668.63K | 743.55K | 56.99K | 42.52K | 29.74K |
| Weighted Average Shares Outstanding (Diluted) | 668.63K | 743.55K | 56.99K | 42.52K | 29.74K |
Currency in USD